This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Disorders of Breast or Breast Lesions
and you are
over 18
years old
The phase for this study is not defined.
Show me locations

The purpose

The purpose of this post-marketing study is to provide prospective evidence that the Magseed and Sentimag® is effective for lesion localization in patients undergoing surgical excision of a breast lesion and to summarize measures of product safety and performance.

Provided treatments

  • Device: Magseed and Sentimag

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03020888. The sponsor of the trial is Endomagnetics Inc and it is looking for 120 volunteers for the current phase.
Official trial title:
A Prospective, Open Label, Post Marketing Study of Magseed and Sentimag in Patients Undergoing Surgical Excision of a Breast Lesion That Requires Preoperative Radiographic Localization